Ara
Toplam kayıt 41, listelenen: 1-10
FIB-4 liver fibrosis index correlates with aortic valve sclerosis in non-alcoholic population
(Wiley, 2024)
Aim: Hepatic fibrosis, a progressive scarring of liver tissue, is commonly caused by non-alcoholic fatty liver disease (NAFLD), which increases the risk of cardiovascular disease. The Fibrosis-4 (FIB-4) index is a non-invasive ...
The predictive value of PRECISE-DAPT score for long-term mortality in patients with acute coronary syndrome complicated by cardiogenic shock
(Springer Medizin, 2024)
Background: Besides its primary clinical utility in predicting bleeding risk in patients with acute coronary syndrome (ACS), the PRECISE-DAPT (Predicting Bleeding Complications in Patients Undergoing Stent Implantation and ...
Long-term protective effects of lamotrigine in a rat ovarian ischemia-reperfusion model
(Elsevier, 2024)
Ovarium torsion is a gynecological emergency that is common in women of reproductive age and requires early diagnosis and intervention. In this study, we aimed to investigate the long-term anatomical, histological and ...
Vibration-controlled transient elastography for non-invasive screening of liver fibrosis and steatosis in Turkish patients with A cross-sectional
(Kare Publishing, 2024)
Background and Aim: The prevalence of fibrosis and steatosis in patients with psoriasis, as determined by vibration-controlled transient elastography (VCTE), has not been evaluated in Turkiye to date. The present cross-sectional ...
Predicting fibrosis progression in non-alcoholic fatty liver disease patients using the FAST Score: A paired biopsy study
(Kare Publishing, 2024)
Background and Aim: This study aimed to investigate the predictive value of various non-invasive scores for identifying the progression of hepatic fibrosis over time in patients with Non-Alcoholic Fatty Liver Disease ...
Addressing the looming epidemic of metabolic dysfunction-associated steatotic liver disease in Pakistan: A call for action
(Kare Publishing, 2024)
The term metabolic dysfunction-associated steatotic liver disease
(MASLD), which evolved from its predecessor, nonalcoholic fatty liver
disease (NAFLD),[1]
COVID-19 Vaccine hesitancy and influencing factors: An example from Turkey
(Professional Medical Publications, 2024)
Objective: To find out the opinions concerning vaccine hesitancy of people and influencing factors who had not received COVID-19 vaccination. Methods: This is a descriptive cross-sectional study. It was carried out between ...
Association of metabolic dysfunction-associated fatty liver disease with cognitive impairment and all-cause dementia: A comprehensive review
(AVES, 2024)
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a significant public health concern, affecting one-third of the global population and posing a risk for progressive liver disease. MAFLD is characterized by ...
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement
(Wiley, 2024)
Background:Following the adoption of new nomenclature for steatotic liver disease, we aimed to build consensus on the use of International Classification of Diseases codes and recommendations for future research and ...
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa
(Wiley, 2024)
Background and Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is common and closely associated with type 2 diabetes (T2D). We assessed ...